HCM — HUTCHMED (China) Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
£1.92bn
Enterprise Value
£1.39bn
Revenue
$630.20m

REG - Hutchmed China Ltd - Vesting of awards under Long Term Incentive Plan
14/03/2025 09:30Announcement
REG - Hutchmed China Ltd - Notice of Extraordinary General Meeting
13/03/2025 09:30Announcement
RCS - Hutchmed China Ltd - Completed Enrollment of Phase II Study
06/03/2025 10:00Announcement
REG - Hutchmed China Ltd - Directorate Change
05/03/2025 10:15Announcement
REG - Hutchmed China Ltd - Overseas Regulatory Announcement
03/03/2025 07:15Announcement
REG - Hutchmed China Ltd - Overseas Regulatory Announcement
28/02/2025 15:00Announcement
REG - Hutchmed China Ltd - Notice of Results
19/02/2025 08:30Announcement
REG - Hutchmed China Ltd - Overseas Regulatory Announcement
28/01/2025 09:15Announcement
RCS - Hutchmed China Ltd - Full Approval for ORPATHYS in China
14/01/2025 07:00Announcement
RCS - Hutchmed China Ltd - China NDA Acceptance for ORPATHYS and TAGRISSO
02/01/2025 07:15Announcement
REG - Hutchmed China Ltd - US$608m Divestment of Non-Core Joint Venture
02/01/2025 07:00Announcement
REG - Hutchmed China Ltd - Overseas Regulatory Announcement
02/01/2025 07:00Announcement
REG - Hutchmed China Ltd - Appointment of Joint Corporate Broker
31/12/2024 08:30Announcement
REG - Hutchmed China Ltd - Blocklisting Six Monthly Return
30/12/2024 08:30Announcement
RCS - Hutchmed China Ltd - HUTCHMED to Receive Milestone Payment from Takeda
13/12/2024 07:00Announcement
RCS - Hutchmed China Ltd - Breakthrough Therapy Designation in China
12/12/2024 07:00Announcement
RCS - Hutchmed China Ltd - HUTCHMED and Innovent Announce ELUNATE Approval
03/12/2024 10:00Announcement
REG - Hutchmed China Ltd - Total Voting Rights
29/11/2024 08:30Announcement
RCS - Hutchmed China Ltd - Continued Inclusion of ORPATHYS in China NRDL
28/11/2024 10:45Announcement
RCS - Hutchmed China Ltd - FRUZAQLA® Launched in Japan by Takeda
22/11/2024 07:00Announcement